A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives
The Journal of Medicine Access · 2022
DOI: 10.1177/23992026221074548 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Medicine Access, 2022. Verfasst von Jamee Ahmed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Science, King's College London, London, UK. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Simultaneous expansion of the Internet and increased globalisation of the pharmaceutical industry have meant medication can be accessed transnationally from both legal and illicit sources. This has coincided with the rise of substandard and falsified medicines (SFMs) online. These products fail to meet regulatory or quality standards and/or are constituted with substandard ingredients, causing undesired pharmacological effects, including possible injury and death. This review aimed to identify original research studies that examined characteristics of SFM online sales, attitudes towards purchasing medicines online and strategies to address this drug safety challenge. Keywords of ‘Substandard’ and ‘Falsified’/‘Counterfeit’ and ‘Medicines’/‘Drugs’ and ‘Online’/‘Internet’ were searched using Web of Knowledge and PubMed databases. Resulting literature, which satisfied the study’s inclusion criteria, was included in the review, and the findings from each paper were assessed. From an initial 185 literature articles, 7 were eligible according to the inclusion criteria to be reviewed. These articles identified studies testing SFMs purchased online, surveys of attitudes and knowledge about SFMs online, and website content analysis to detect illegal online sales. Challenges identified were lack of knowledge and awareness among consumers and physicians, in addition to the use of direct-to-consumer-advertising, via Internet platforms and social media, providing easy access to SFMs. Despite this, medicine authentication technology, website verification approaches and new detection methods were identified as potential solutions specific to online SFM sales. To address online sales of SFMs, more robust research, greater awareness/educational programmes, analytical detection methods and more stringent online global governance are required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Science, King's College London, London, UK.
- Department of Anesthesiology and Division of Infectious Diseases and Global Public Health, School of Medicine, UC San Diego, La Jolla, CA, USA.
ORCID-Profile: Laura Modica de Mohac, Bahijja Tolulope Raimi-Abraham
Zitieren
APA
Ahmed, J., Modica de Mohac, L., Mackey, T. K., & Raimi-Abraham, B. T. (2022). A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives. The Journal of Medicine Access. https://doi.org/10.1177/23992026221074548
Vancouver
Ahmed J, Modica de Mohac L, Mackey TK, Raimi-Abraham BT. A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives. The Journal of Medicine Access. 2022. doi:10.1177/23992026221074548
BibTeX
@article{Ahmed2022,
author = {Ahmed, Jamee and Modica de Mohac, Laura and Mackey, Tim K and Raimi-Abraham, Bahijja Tolulope},
title = {A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives},
journal = {The Journal of Medicine Access},
year = {2022},
doi = {10.1177/23992026221074548}
}
EUVIMED